Portfolio company
nanoTherics
United Kingdom · £1.1m raised
Raised
£1.1m
Latest stage
Seed
Rounds recorded
1
Backed by
2 investors
Sectors
About
This company develops magnetic nanoparticle heating and transfection systems for researchers in the fields of gene therapy, drug delivery and genetic disease disorders.
SourceFunding history · 1
Similar companies
Sonothera Therapeutics
This company develops a non-viral gene therapy platform using ultrasound and microbubbles to deliver genetic medicines for patients with serious diseases.
Nanograb
This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
NANOLYZE
This company develops waveguide microscopy equipment for real-time analysis of nanoparticles to support researchers in drug development and nanomedicine.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
SonoThera™
This company develops an ultrasound-guided non-viral platform to deliver genetic medicines for patients with chronic and rare diseases.
Nuntius Therapeutics
This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.
NanoCell Therapeutics, Inc.
The company develops non-viral, DNA-based in-vivo gene therapy platforms to treat oncology and autoimmune diseases for patients and healthcare providers.
